Catherine Kenny
Episode 3 of the Innovation and the Future of Pharmacovigilance podcast, hosted by Indy Ahluwalia, titled "Catherine Kenny" was published on November 27, 2023 and runs 50 minutes.
November 27, 2023 ·50m · Innovation and the Future of Pharmacovigilance
Summary
Send us Fan Mail Ever wondered how a company navigates the complexities of Pharmacovigilance (PV)? Catherine Kenny, managing partner and co-founder of Signal Pharma Experts, takes us on an enlightening journey through it all. With years of experience spanning from a generics company to a director and head of Benefit Risk at Diamond Pharma Services, Catherine shares her invaluable insights into the intriguing world of PV. Does the prospect of smaller firms utilizing AI, in the face of budgeta...
Episode Description
Ever wondered how a company navigates the complexities of Pharmacovigilance (PV)? Catherine Kenny, managing partner and co-founder of Signal Pharma Experts, takes us on an enlightening journey through it all. With years of experience spanning from a generics company to a director and head of Benefit Risk at Diamond Pharma Services, Catherine shares her invaluable insights into the intriguing world of PV.
Does the prospect of smaller firms utilizing AI, in the face of budgetary and resource limitations, seem daunting to you? Let’s take a look at it from a different angle. Imagine these firms joining forces to tackle larger safety database vendors - interesting, isn't it? Our discussion with Catherine brings in unique perspectives about managing regulatory inspections, project planning, and documentation. Plus, we emphasize on the oft-overlooked yet vital aspect of team spirit between departments in smaller firms.
Catherine unveils the realities of running a risk management department in a small company, underscoring the indispensability of real-world data, risk minimization, and signal detection. So buckle up for a thought-provoking conversation that uncovers a spectrum of insights into the world of PV.
Similar Episodes
Apr 11, 2026 ·58m
Apr 8, 2026 ·49m
Apr 5, 2026 ·58m